SQA
LGND icon

Simon Quick Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Simon Quick Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-223
Closed -$14K – 608
2019
Q4 		$14K Buy
+223
New +$14.9K 0.01% 356
2017
Q3 		– Sell
-261
Closed -$20K – 524
2017
Q2 		$20K Buy
+261
New +$18.3K 0.01% 181

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Simon Quick Advisors's LGND Position: Q1 2020 in Review

Simon Quick Advisors sold out of Ligand Pharmaceuticals (LGND) in Q1 2020, closing a stake of 223 shares — an estimated $14K sold.

Simon Quick Advisors first reported a position in LGND in Q2 2017 and held it in 2 quarters. The position peaked at $20K in Q2 2017. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2020.

  • Simon Quick Advisors reported no remaining Ligand Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Simon Quick Advisors sold 223 Ligand Pharmaceuticals shares in Q1 2020, an estimated $14K.
  • Simon Quick Advisors first reported a position in Ligand Pharmaceuticals in Q2 2017 and held it in 2 quarters.
  • Simon Quick Advisors's Ligand Pharmaceuticals position peaked at $20K in Q2 2017.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2020.

Based on Simon Quick Advisors's 13F filing for Q1 2020, filed 9 Apr 2020.